Subjective, psychomotor, and physiological effects profile of hydrocodone/acetaminophen and oxycodone/acetaminophen combination products

Pain Medicine

Volumn 9, Issue 4, 2008, Pages 433-443

  Zacny, James P ^a   Gutierrez, Sandra ^a  

^a THE UNIVERSITY OF CHICAGO   (United States)

Author keywords

Abuse liability; Human; Prescription opioids; Psychomotor; Subjective effects; Volunteer

Indexed keywords

ANALGESIC AGENT; HYDROCODONE PLUS PARACETAMOL; LACTOSE; OXYCODONE PLUS PARACETAMOL; PARACETAMOL; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONCENTRATION LOSS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG RESPONSE; DRUG SAFETY; DRUNK SENSATION; FEMALE; FLUSHING; HUMAN; HUMAN EXPERIMENT; MALE; MIOSIS; NAUSEA; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; PHARMACIST; PHYSICIAN; PRESCRIPTION; PRURITUS; PSYCHOMOTOR DISORDER; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; SKIN TINGLING; STATISTICAL SIGNIFICANCE; STOMACH DISEASE; SWEATING; THOUGHT DISORDER; TREATMENT DURATION; UNPLEASANT SENSATION; XEROSTOMIA;

EID: 44249114538     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2007.00359.x     Document Type: Article

References (37)

1. CA Marco MC Plewa N Buderer C Black A Roberts Comparison of oxycodone and hydrocodone for the treatment of acute pain associated with fractures: A double-blind, randomized, controlled trial Acad Emerg Med 12 2005 282 288
2. Substance Abuse and Mental Health Services Administration Results from the 2005 National Survey on Drug Use and Health: National Findings. Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. SMA 06-4194 2006 Substance Abuse and Mental Health Services Administration Rockville, MD
3. LR Derogatis SCL-90-R: Symptom Checklist-90-R 1975 NCS Pearson, Inc Minneapolis, MN
4. LR Derogatis SCL-90-R: Symptom Checklist-90-R: Administration, Scoring and Procedures Manual 3rd edn 1994 National Computer Systems, Inc Minneapolis, MN
5. ML Selzer The Michigan Alcoholism Screening Test: The quest for a new diagnostic instrument Am J Psychiatry 127 1971 1653 1658
6. MB First RL Spitzer M Gibbons JB Williams Structured Clinical Interview for DSM-IV Axis I Disorders—Clinical Version—SCID-I Administration Booklet 1997 American Psychiatric Press Washington, DC
7. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR. (Text Revision) 2000 American Psychiatric Association Washington, DC
8. CA Haertzen Development of scales based on patterns of drug effects, using the Addiction Research Center Inventory (ARCI) Psychol Rep 18 1966 163 194
9. WR Martin JW Sloan JD Sapira DR Jasinski Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man Clin Pharmacol Ther 12 1971 245 258
10. HF Fraser GD van Horn WR Martin AB Wolbach H Isbell Methods for evaluating addiction liability. (a) “attitude” of opiate addicts toward opiate-like drugs, (b) a short-term “direct” addiction test J Pharmacol Exp Ther 133 1961 371 387
11. KL Preston GE Bigelow WK Bickel IA Liebson Drug discrimination in human postaddicts: Agonist-antagonist opioids J Pharmacol Exp Ther 250 1989 184 196
12. JP Zacny S Gutierrez Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers Psychopharmacology (Berl) 170 2003 242 254
13. RR Griffiths GE Bigelow NA Ator Principles of initial experimental drug abuse liability assessment in humans Drug Alcohol Depend 70 S 2003 S41 S54
14. DR Jasinski Assessment of the abuse potentiality of morphine-like drugs (methods used in man) Martin WR Drug Addiction I. Morphine, Sedative-Hypnotic, and Alcohol Dependence. Handbook of Experimental Pharmacology Vol. 45 1977 Springer Heidelberg 197 258
15. AD Baddeley A three-minute reasoning test based on grammatical transformation Psychon Sci 10 1968 341 342
16. D Wechsler The Measurement and Appraisal of Adult Intelligence 1958 Williams & Wilkins Baltimore, MD
17. EJ Nuotto K Korttila Evaluation of a new computerized psychomotor test battery: Effects of alcohol Pharmacol Toxicol 68 1991 360 365
18. A Wetherell Performance tests Environ Health Perspect 104 suppl. 2 1996 247 273
19. JG Hannington-Kiff Measurement of recovery from outpatient general anaesthesia with a simple ocular test BMJ 3 1970 132 135
20. J Riley JR Ross D Rutter No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients Support Care Cancer 14 2006 56 64
21. JP Zacny S Gutierrez SA Bolbolan Profiling the subjective, psychomotor, and physiological effects of a hydrocodone/acetaminophen product in recreational drug users Drug Alcohol Depend 78 2005 243 252
22. NR Eade L Lasagna A comparison of acetophenetidin and acetaminophen. II. Subjective effects in healthy volunteers J Pharmacol Exp Ther 155 1967 301 308
23. WB Pickworth SA Klein FR George JE Henningfield Acetaminophen fails to inhibit ethanol-induced subjective effects in human volunteers Pharmacol Biochem Behav 41 1991 189 194
24. CM Bradley AN Nicholson Studies on performance with aspirin and paracetamol and with the centrally acting analgesics meptazinol and pentazocine Eur J Clin Pharmacol 32 1987 135 139
25. J Zacny G Bigelow P Compton College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: Position statement Drug Alcohol Depend 69 2003 215 232
26. LD Johnston PM O'Malley JG Bachman JE Schulenberg Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2005. (NIH Publication no. 06-5882) 2006 National Institute on Drug Abuse Bethesda, MD
27. WM Compton ND Volkow Major increases in opioid analgesic abuse in the United States: Concerns and strategies Drug Alcohol Depend 81 2006 103 107
28. JP Zacny Characterizing the subjective, psychomotor, and physiological effects of a hydrocodone combination product (Hycodan®) in non-drug-abusing volunteers Psychopharmacology (Berl) 165 2003 146 156
29. MJ Kreek G Bart C Lilly KS Laforge DA Nielsen Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments Pharmacol Rev 57 2005 1 26
30. TH Kelly G Robbins CA Martin Individual differences in drug abuse vulnerability: D-amphetamine and sensation-seeking status Psychopharmacology (Berl) 189 2006 17 25
31. NP Katz EH Adams JC Benneyan Foundations of opioid risk management Clin J Pain 23 2007 103 118
32. KM Conley AY Toledano JL Apfelbaum JP Zacny The modulating effects of a cold water stimulus on opioid effects in volunteers Psychopharmacology (Berl) 131 1997 313 320
33. JP Zacny MA McKay AY Toledano The effects of a cold-water immersion stressor on the reinforcing and subjective effects of an opioid in healthy volunteers Drug Alcohol Depend 42 1996 133 142
34. FM Borgbjerg K Nielsen J Franks Experimental pain stimulates respiration and attenuates morphine-induced respiratory depression: A controlled study in human volunteers Pain 64 1996 123 128
35. E Bruera K Macmillan J Hanson RN MacDonald The cognitive effects of the administration of narcotic analgesics in patients with cancer pain Pain 39 1989 13 16
36. MD Sullivan MJ Edlund D Steffick J Unutzer Regular use of prescribed opioids: Association with common psychiatric disorders Pain 119 2005 95 103
37. K Dowling CL Storr HD Chilcoat Potential influences on initiation and persistence of extramedical prescription pain reliever use in the US population Clin J Pain 22 2006 776 783